A small hypoxia signature predicted pCR response to bevacizumab in the neoadjuvant GeparQuinto breast cancer trial - Karn, Thomas; Meissner, Tobias; Weber, Karsten E.; Solbach, Christine; Denkert, Carsten; Engels, Knut; Fasching, Peter A.; Sinn, Bruno V.; Schrader, Iris; Budczies, Jan; Marmé, Frederik; Müller, Volkmar; et al. (Clinical cancer research, 2020)
Gesehen am 13.04.2021